All India Drug Action Network

India Bans 328 Combination Drugs in Setback for Pharma Companies

HC Seeks Centre’s Stand on PIL Against Ban on Private Manufacture, Sale of Oxytocin

Health Activists Urge BJP to Recall Drug Labels Used as Proxy Party Advertisement

Abbott's Absorb stent, which dissolves back into the bloodstream over time. Photo courtesy: Abbott

Amidst Safety Fears, India Sends Controversial Abbott Stent for Clinical Trials, Won’t Pull It Back